Nostrum BioDiscovery has spun out of a pair of Spanish research institutions with ambitions to use supercomputer-powered computational simulations to improve drug discovery. And the startup has picked up seed funding to advance technology it sees as lowering the cost of early-stage research.
Continue reading here.